Cataract Repair: 20-Year Outcomes In Diabetic Patients Overview This study aimed to assess the 20-year outcomes in terms of best-corrected visual acuity (BCVA) and subjective visual function, as measured by the VF-14 questionnaire, following cataract surgery in individuals with type 2 diabetes compared to those without diabetes. A prospective, longitudinal, population-based cohort study
Ophthalmology
Skin Lightening: Topical Approaches To Treatment
Skin Lightening: Topical Approaches To Treatment Overview The recent removal of hydroquinone from over-the-counter skin lightening products has created a demand for modern formulations that effectively address skin pigmentation issues. A successful skin lightening formulation should be non-irritating to prevent post-inflammatory hyperpigmentation, penetrate effectively to reach the epidermal/dermal junction, incorporate anti-inflammatory ingredients,
Eyelid Carcinoma (SGC): A Tool To Predict Recurrence
Eyelid Carcinoma (SGC): A Tool To Predict Recurrence Overview Eyelid sebaceous gland carcinoma (SGC) is a highly malignant condition with a significant recurrence risk. This study aimed to create a predictive nomogram for SGC recurrence based on risk factors. A retrospective study involving 391 patients from one hospital (304) and grassroots hospitals (87)
Cognitive Behavioral Therapy In Patients With Insomnia And Chronic Fatigue
Cognitive Behavioral Therapy In Patients With Insomnia And Chronic Fatigue Overview This study delves into the relationship between insomnia, chronic fatigue, and the response to cognitive behavioral therapy for insomnia (CBT-I). The research, a secondary analysis of data from a community-based randomized controlled trial, encompassed 1717 participants with self-reported insomnia. The primary
Visual Field Defects in Patients with Pituitary Tumors
Visual Field Defects in Patients with Pituitary Tumors Overview Automated perimetry is a standardized technique for assessing the visual field, commonly using the Humphrey Field Analyser (HFA) with the 24-2 or 30-2 test patterns. This study aimed to determine if the 24-2 test pattern could yield similar outcomes as the 30-2 pattern
Ocular Surgery In Infants And Post-Op Eye Drop Risks
Ocular Surgery In Infants And Post-Op Eye Drop Risks Overview This clinical observational cohort study delves into the prevalence and risk factors associated with hypothalamus-pituitary-adrenal (HPA) axis suppression in infants subjected to glucocorticoid (GC) eye drops subsequent to ocular surgery, focusing on cataract and glaucoma procedures. The research aims to discern the
Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
Eyelid Rhabdomyosarcoma Survival In Children's Oncology Overview Survival outcomes in Orbital Rhabdomyosarcoma (ORMS) typically show excellent results, especially in low-risk cases (stage 1, group I-III, embryonal RMS). However, long-term follow-up data on low-risk ORMS and less common subgroups treated in recent Children's Oncology Group (COG) trials were previously unreported. To fill this
primary adenocarcinoma of the orbit: a case study
primary adenocarcinoma of the orbit: a case study Introduction Primary mucinous adenocarcinoma is an anomalous neoplasm with a tendency to frequently recur and metastasize. It is a rare neoplasm with no predisposing factors or etiology. It can often be seen throughout the body, especially in the head or neck. Symptoms include abdominal
Dry Eye Disease and Dehydration
Dry Eye Disease and Dehydration Overview Can greater habitual water intake lower the risk of dry eye disease (DED)? Dry eye disease is a complex disease of the tear film and ocular surface. It causes discomfort, visual disturbance, and the risk of damage to the ocular surface. DED is a condition when a
macular edema therapy using dexamethasone nanoparticle suspension
macular edema therapy using dexamethasone nanoparticle suspension PURPOSE To determine the effectiveness and safety of a new topical nanoparticle dexamethasone ophthalmic suspension OCS-01 (Oculis SA, Lausanne, Switzerland) in the treatment of diabetic macular edema (DME). STUDY BACKGROUND Diabetic macular edema (DME) is the main cause of visual impairment in patients with diabetic retinopathy (DR).
